Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Dudley

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Antimicrobial Agents and Chemotherapy|September 1, 1993
Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infectionC R Marchbanks, J R McKiel, D H Gilbert, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected PatientsM Trang, D C Griffith, S M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteriaS Chamberland, J Blais, M Hoang, et al.
Cancer|December 15, 1992
High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trialM R Posner, J W Darnowski, A B Weitberg, et al.
The Journal of Antibiotics|January 2, 2001
SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephemsT W Glinka, A Cho, Z J Zhang, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2022
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility BreakpointsS M Bhavnani, M Trang, D C Griffith, et al.
The Journal of Infectious Diseases|January 1, 1993
2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trialM J Browne, K H Mayer, S B Chafee, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Antimicrobial Agents and Chemotherapy|September 1, 1993
Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infectionC R Marchbanks, J R McKiel, D H Gilbert, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2021
Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected PatientsM Trang, D C Griffith, S M Bhavnani, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteriaS Chamberland, J Blais, M Hoang, et al.
Cancer|December 15, 1992
High-dose intravenous zidovudine with 5-fluorouracil and leucovorin. A phase I trialM R Posner, J W Darnowski, A B Weitberg, et al.
The Journal of Antibiotics|January 2, 2001
SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephemsT W Glinka, A Cho, Z J Zhang, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2022
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility BreakpointsS M Bhavnani, M Trang, D C Griffith, et al.
The Journal of Infectious Diseases|January 1, 1993
2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trialM J Browne, K H Mayer, S B Chafee, et al.
Pageof 7